ARTICLE | Company News
Neuren, U.S. Army neurology news
September 15, 2008 7:00 AM UTC
Neuren received a $5.5 million grant from the U.S. Army to fund a Phase II trial of NNZ-2566 to treat traumatic brain injury that is expected to start early next year. The compound is a small molecu...